Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标

2018-06-19 国外消化科相关专家小组（统称） Aliment Pharmacol Ther. 2018 Jun 19.

克罗恩病抗纤维化狭窄治疗目标

纤维化性狭窄是克罗恩（CD）常见的并发症，约有一半的患者会受此影响。本文主要针对克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标提出共识建议。

中文标题：

2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标

英文标题：

An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn''s disease.

发布机构：

国外消化科相关专家小组（统称）

发布日期：

2018-06-19

简要介绍：

纤维化性狭窄是克罗恩（CD）常见的并发症，约有一半的患者会受此影响。本文主要针对克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标提出共识建议。 

拓展指南：与克罗恩病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标)] GetToolGuiderByIdResponse(projectId=1, id=217bf1c00160e225, title=2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标, enTitle=An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn''s disease., guiderFrom=Aliment Pharmacol Ther. 2018 Jun 19., authorId=null, author=, summary=纤维化性狭窄是克罗恩（CD）常见的并发症，约有一半的患者会受此影响。本文主要针对克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标提出共识建议。 , cover=, journalId=null, articlesId=null, associationId=950, associationName=国外消化科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jun 19 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>纤维化性狭窄是克罗恩（CD）常见的并发症，约有一半的患者会受此影响。本文主要针对克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标提出共识建议。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>克罗恩病</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=fccaa1c0015e71b8" title="2018 ACG临床指南：成人克罗恩病的管理" target=_blank>2018 ACG临床指南：成人克罗恩病的管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=8d9001c001a6e962" title="2017 台湾克罗恩病管理指南" target=_blank>2017 台湾克罗恩病管理指南</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=e28081c001a341c3" title="2017 ECCO/ESCP共识：克罗恩病的手术治疗" target=_blank>2017 ECCO/ESCP共识：克罗恩病的手术治疗</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=c60d51c001a1e4e0" title="2017 ACPGBI共识：克罗恩病肛周瘘管的手术治疗" target=_blank>2017 ACPGBI共识：克罗恩病肛周瘘管的手术治疗</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=806bb1c001a109e2" title="2016 AGA指南：外科手术后克罗恩病的管理" target=_blank>2016 AGA指南：外科手术后克罗恩病的管理</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E5%85%8B%E7%BD%97%E6%81%A9%E7%97%85" target=_blank>有关克罗恩病更多指南</a></ul>, tagList=[TagDto(tagId=984, tagName=克罗恩病), TagDto(tagId=76769, tagName=抗纤维化狭窄), TagDto(tagId=49504, tagName=治疗目标)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6083, appHits=179, showAppHits=0, pcHits=4306, showPcHits=2197, likes=149, shares=9, comments=6, approvalStatus=1, publishedTime=Mon Jun 25 21:47:38 CST 2018, publishedTimeString=2018-06-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jun 25 21:47:38 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:27:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标)])
2018 多学科专家共识：克罗恩病抗纤维化狭窄治疗的标准化定义，诊断和治疗目标
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1075653, encodeId=f77910e565360, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:15:02 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075652, encodeId=ec9f10e5652f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:14:38 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327405, encodeId=9a1f32e405b3, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Jun 27 10:15:59 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327011, encodeId=4e4332e0118d, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:23 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326998, encodeId=2d9132699817, content=不错的视频值得拥有哦!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jun 25 23:00:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2021-12-01 14号射手

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1075653, encodeId=f77910e565360, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:15:02 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075652, encodeId=ec9f10e5652f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:14:38 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327405, encodeId=9a1f32e405b3, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Jun 27 10:15:59 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327011, encodeId=4e4332e0118d, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:23 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326998, encodeId=2d9132699817, content=不错的视频值得拥有哦!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jun 25 23:00:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2021-12-01 14号射手

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1075653, encodeId=f77910e565360, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:15:02 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075652, encodeId=ec9f10e5652f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:14:38 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327405, encodeId=9a1f32e405b3, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Jun 27 10:15:59 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327011, encodeId=4e4332e0118d, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:23 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326998, encodeId=2d9132699817, content=不错的视频值得拥有哦!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jun 25 23:00:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-27 131****1460

    学习了受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1075653, encodeId=f77910e565360, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:15:02 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075652, encodeId=ec9f10e5652f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:14:38 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327405, encodeId=9a1f32e405b3, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Jun 27 10:15:59 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327011, encodeId=4e4332e0118d, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:23 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326998, encodeId=2d9132699817, content=不错的视频值得拥有哦!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jun 25 23:00:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 清风拂面

    谢谢分享学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1075653, encodeId=f77910e565360, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:15:02 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075652, encodeId=ec9f10e5652f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160929/IMG57EBFB2F217CC3250.jpg, createdBy=e8381958770, createdName=14号射手, createdTime=Wed Dec 01 02:14:38 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327405, encodeId=9a1f32e405b3, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Jun 27 10:15:59 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327011, encodeId=4e4332e0118d, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jun 25 23:20:23 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326998, encodeId=2d9132699817, content=不错的视频值得拥有哦!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Jun 25 23:00:16 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 1e1b8538m79(暂无匿称)

    不错的视频值得拥有哦!

    0

相关指南

2018 ACG临床指南：成人克罗恩病的管理

美国胃肠病学院(ACG,American College of Gastroenterology) · 2018-03-27

2018 JSGE循证临床实践指南：炎症性肠病

日本皮肤病协会(JDA,Japanese Dermatological Association) · 2018-02-10

2017 台湾克罗恩病管理指南

台湾炎症性肠病学会(Taiwan Society of Inflammatory Bowel Disease) · 2017-06-12

2017 ECCO/ESCP共识：克罗恩病的手术治疗

暂未更新 · 2017-05-11

2017 ACPGBI共识：克罗恩病肛周瘘管的手术治疗

大不列颠及爱尔兰肛肠协会(ACPGBI,Association of Coloproctology of Great Britain and Ireland) · 2017-04-07

2016 AGA指南：外科手术后克罗恩病的管理

美国胃肠病协会(AGA,American Gastroenterological Association) · 2016-11-10

Baidu
map
Baidu
map
Baidu
map